Announce Date | 07/24/2025 |
EPS Normalized Actual | $0.85 (Beat by $0.036) |
EPS GAAP Actual | $0.85 (Beat by $0.036) |
Revenue Actual | $2.09B |
Revenue Surprise | Beat by $2090M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.76825 |
EPS GAAP Estimate | $0.76825 |
Revenue Estimate | $1.233433333B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.75 | 18.72 | 4.64406 | 4.84999 | 1 |
Dec 2028 | 4.55 | 19.54 | 4.42339 | 4.6885 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.69 | -1.46 | 2.09B | 14.26% | 878M |
FQ1 2025 (Mar 2025) | 0.687 | 0.687 | 2.09B | 19.9% | 2090M |
FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 2.029B | 18.78% | 2029M |
FQ3 2024 (Sep 2024) | 0.531 | 0.531 | 1.904B | 23.79% | 1904M |
FQ2 2024 (Jun 2024) | 0.39 | 0.39 | 1.792B | 20.03% | 1792M |
FQ1 2024 (Mar 2024) | 0 | 0 | 1.674B | 8.42% | 1674M |
FQ4 2023 (Dec 2023) | 0 | 0 | 1.648B | 4% | 1648M |
FQ3 2023 (Sep 2023) | 491.3 | 491.3 | 1.451B | -7.31% | 1451M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.76825
Consensus Revenue Estimates
1.233433333B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.04 | -- | 1.04 | 1.04 | 5 |
FQ3 2027 (Sep 2027) | 0.97 | -- | 0.97 | 0.97 | 5 |
FQ2 2027 (Jun 2027) | 0.96 | -- | 0.96 | 0.96 | 5 |
FQ1 2027 (Mar 2027) | 0.93 | -- | 0.93 | 0.93 | 5 |
FQ4 2026 (Oct 2026) | 0.89 | -- | 0.8723 | 0.91572 | 7 |
FQ3 2026 (Jul 2026) | 0.82 | -- | 0.80369 | 0.84369 | 4 |
FQ2 2026 (Jun 2026) | 0.86 | 180.23 | 0.8309 | 0.89495 | 4 |
FQ1 2026 (Mar 2026) | 0.81 | 15.19 | 0.78259 | 0.84292 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.5B | -- | 1.5B | 1.5B | 9 |
FQ3 2027 (Sep 2027) | 1.44B | -- | 1.44B | 1.44B | 9 |
FQ2 2027 (Jun 2027) | 1.43B | -- | 1.43B | 1.43B | 9 |
FQ1 2027 (Mar 2027) | 1.39B | -- | 1.39B | 1.39B | 9 |
FQ4 2026 (Oct 2026) | 1.33B | -- | 1.31B | 1.36B | 4 |
FQ3 2026 (Jul 2026) | 1.27B | -- | 1.25B | 1.3B | 4 |
FQ2 2026 (Jun 2026) | 1.31B | -60.15 | 1.27B | 1.35B | 4 |
FQ1 2026 (Mar 2026) | 1.27B | -64.05 | 1.24B | 1.31B | 7 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.77 | -0.69 | -1.46 | 211.59% |
FQ1 2025 (Mar 2025) | 0.687 | 0.687 | 100% | |
FQ4 2024 (Dec 2024) | 0.62 | 0.62 | 100% | |
FQ3 2024 (Sep 2024) | 0.531 | 0.531 | 100% | |
FQ2 2024 (Jun 2024) | 0.39 | 0.39 | 100% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 491.3 | 491.3 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $1.21B | $2.09B | $878M | 42.01% |
FQ1 2025 (Mar 2025) | $0B | $2.09B | $2090M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.03B | $2029M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.9B | $1904M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.79B | $1792M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.67B | $1674M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.65B | $1648M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.45B | $1451M | 100% |